Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
This study aims to evaluate the relationship between human ribophorin II (<i>RPN2</i>) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for <i>p</i>-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC)...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/18/4118 |